Singapore markets closed

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9048+0.0017 (+0.19%)
As of 01:31PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
32,786
24,459
18,890
30,373
-
Other short-term investments
24,147
33,747
106,077
26,954
-
Total cash
56,933
58,206
124,967
57,327
-
Net receivables
30,550
40,320
15,472
15,973
-
Inventory
5,522
9,118
6,616
1,638
-
Other current assets
6,261
8,259
7,412
-
-
Total current assets
99,266
115,903
154,467
88,983
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,730
13,594
26,438
34,247
-
Accumulated depreciation
-1,704
-10,807
-14,551
-13,676
-
Net property, plant and equipment
1,026
2,787
11,887
20,571
-
Other long-term assets
3,055
640
974
824
-
Total non-current assets
17,959
18,376
12,861
21,395
-
Total assets
117,225
134,279
167,328
110,378
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
7,229
-
-
-
-
Accounts payable
7,142
22,508
3,795
3,707
-
Accrued liabilities
8,847
14,193
15,160
15,903
-
Deferred revenues
17,039
13,514
10,511
3,018
-
Other current liabilities
3,642
4,997
13,506
-
-
Total current liabilities
53,267
65,211
63,554
40,841
-
Non-current liabilities
Long-term debt
52,373
39,448
19,914
19,815
-
Deferred revenues
-
-
-
0
1,404
Other long-term liabilities
39,944
42,264
52,727
5,045
-
Total non-current liabilities
92,602
82,684
73,400
35,511
-
Total liabilities
145,869
147,895
136,954
76,352
-
Stockholders' equity
Common stock
175
174
172
169
-
Retained earnings
-1,407,550
-1,382,459
-1,323,886
-1,305,972
-
Accumulated other comprehensive income
8
-153
-102
-4
-
Total stockholders' equity
-28,644
-13,616
30,374
34,026
-
Total liabilities and stockholders' equity
117,225
134,279
167,328
110,378
-